May 21, 2016 | Cardiology, Inside, Research
From left: Rami O. Tadros, MD, FACS; James F. McKinsey, MD, FACS; and Michael L. Marin, MD, FACS, are using a new-generation implantable device to treat complex thoracoabdominal aortic aneurysms.
Physicians at The Mount Sinai Hospital were among the first in the nation to implant an investigational device, a fabric and metal mesh tube known as a stent graft, as part of a clinical trial to treat aneurysms located in the thoracic/abdominal area of the aorta. Mount Sinai is one of only six institutions in the nation granted approval by the U.S. Food and Drug Administration to test the safety and initial feasibility of the device in patients.
The stent graft is used to strengthen the inner lining of the aorta—the main artery that carries blood from the heart to organs—in patients where the aortic walls have weakened and caused a balloon-type bulge known as an aneurysm to grow. Once implanted, the device serves to direct blood flow away from the aneurysm, causing it to shrink in size. If not repaired, the aneurysm can rupture and result in life-threatening internal bleeding. (more…)
May 21, 2016 | Cardiology, Inside, Research
Routine mammograms used for the early detection of breast cancer may also provide women with an early warning of cardiovascular disease, according to a recent study led by Laurie Margolies, MD, Associate Professor of Radiology at the Icahn School of Medicine at Mount Sinai, and Chief of Breast Imaging at the Dubin Breast Center at The Mount Sinai Hospital. (more…)
Updated on Jun 30, 2022 | Research, Your Health
Guest post by Ilana Kersch, MS RD CDN, Senior Dietitian at the Mount Sinai Hospital. Ilana works as part of the inpatient liver transplant team in conjunction with the Recanati Miller Transplant Institute, and provides nutrition care for patients pre- and post-hepatobiliary surgery.
In recent decades, non-alcoholic fatty liver disease (NAFLD) has become an important cause of liver disease in the US due to its association with rising prevalence of obesity and type 2 diabetes. It is estimated that approximately 30% of the US population now has some degree of non-alcoholic fatty liver, and ~2- 5% of the population have fatty liver which has progressed to non-alcoholic steatohepatitis (NASH). If untreated, NAFLD and NASH can progress to liver cirrhosis and malignancy, and is quickly becoming a major indication for listing for liver transplant. (more…)
Updated on Jun 30, 2022 | Inside, Research
Kateri Moore, DVM, left, with graduate students Andreia Gomes and Jeffrey Bernitz
For scientists who study stem cells, the ability to produce hematopoietic stem/progenitor cells (HSPCs) in the lab and then transplant them into patients with blood disorders has been a long-sought-after goal. Recently, the field took a step closer to that milestone when researchers at the Icahn School of Medicine at Mount Sinai identified cells in the embryos and placentas of mice that are actually precursors to HSPCs. Hematopoiesis is the daily process by which the human body generates all of the different types of cells found in the blood and immunological system. (more…)
Updated on Jun 30, 2022 | Cardiology, Inside, Research, Your Health
Casey Crump, MD, PhD
Physical fitness in late adolescence may reduce the risk of developing type 2 diabetes later in life, according to a new study from the Icahn School of Medicine at Mount Sinai that appeared online in the March 8, 2016, issue of the Annals of Internal Medicine.
Researchers—led by Casey Crump, MD, PhD, Vice Chair for Research in the Department of Family Medicine and Community Health at Icahn School of Medicine at Mount Sinai—evaluated data on the aerobic capacity of 1.5 million males who were military conscripts in Sweden between 1969 and 1997. The scientists then compared the men’s aerobic capacity to their medical diagnoses that were made between 1987 and 2012, when the men were a maximum age of 62. (more…)
Updated on Jun 30, 2022 | Inside, Research, School
Mount Sinai School of Medicine Student Research Day 2016.
Five Icahn School of Medicine at Mount Sinai students were chosen to give oral presentations of their basic and clinical research projects at Mount Sinai’s 21st Annual Medical Student Research Day, on Thursday, March 10, in Stern Auditorium. Mitra Heshmati, PhD, Imikomobong Ibia, Emily Leven, Paul Peng, PhD, and Elizabeth Tarras received a prize of $250 each for their work, which was carried out under the supervision of faculty mentors: Scott Russo, PhD, Associate Professor of Neuroscience; Charles Mobbs, PhD, Professor of Medicine, Geriatrics and Palliative Medicine, and Neuroscience; Eyal Shemesh, MD, Associate Professor of Pediatrics, and Psychiatry; Joshua Brody, MD, Assistant Professor of Medicine (Hematology and Medical Oncology); and Rosanne Leipzig, MD, PhD, Professor of Medicine, Geriatrics and Palliative Medicine, and Population Health Science and Policy. Christina Wyatt, MD, Associate Director, Medical Student Research Office, moderated the oral presentations. (more…)
